Jonathan Maher
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Genomics, phytochemicals, and oxidative stress 18
- Glutathione Transferases and Polymorphisms 8
- Oncology 24
- Drug Transport and Resistance Mechanisms 22
- Co-authors
- Curtis D. Klaassen (23 shared papers)Masayuki Yamamoto (15 shared papers)Angela L. Slitt (12 shared papers)Xingguo Cheng (8 shared papers)Takafumi Suzuki (4 shared papers)Matthew Z. Dieter (6 shared papers)Nathan J. Cherrington (11 shared papers)Hozumi Motohashi (3 shared papers)
- Journals
- Drug Metabolism and Disposition (9 papers)Toxicology and Applied Pharmacology (6 papers)Molecular and Cellular Biology (3 papers)Toxicological Sciences (3 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Jonathan Maher
53 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 116
- Pharmacology 675
- Oncology 1.3k
- Molecular Biology 2.2k
- Pediatrics, Perinatology and Child Health 485
- Biochemistry 177
Countries citing papers authored by Jonathan Maher
This map shows the geographic impact of Jonathan Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Maher more than expected).
Fields of papers citing papers by Jonathan Maher
This network shows the impact of papers produced by Jonathan Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Maher. The network helps show where Jonathan Maher may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 452 | |
| 2 | 2007 | 273 | |
| 3 | 2005 | 213 | |
| 4 | 2010 | 209 | |
| 5 | 2010 | 202 | |
| 6 | 2011 | 194 | |
| 7 | 2006 | 184 | |
| 8 | 2010 | 173 | |
| 9 | 2004 | 172 | |
| 10 | 2005 | 171 | |
| 11 | 2005 | 149 | |
| 12 | 2007 | 128 | |
| 13 | 2008 | 124 | |
| 14 | 2007 | 114 | |
| 15 | 2005 | 111 | |
| 16 | 2008 | 98 | |
| 17 | 2007 | 97 | |
| 18 | 2018 | 90 | |
| 19 | 2006 | 88 | |
| 20 | 2009 | 75 |
About Jonathan Maher
Jonathan Maher is a scholar working on Molecular Biology, Oncology, Pharmacology, Pediatrics, Perinatology and Child Health and Immunology, having authored 53 papers that have together received 4.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Genomics, phytochemicals, and oxidative stress (18 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Glutathione Transferases and Polymorphisms (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Pharmacology (675 citations), Oncology (1.3k citations), Molecular Biology (2.2k citations), Pediatrics, Perinatology and Child Health (485 citations) and Biochemistry (177 citations). Jonathan Maher has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Curtis D. Klaassen, Masayuki Yamamoto, Angela L. Slitt, Xingguo Cheng, Takafumi Suzuki, Matthew Z. Dieter, Nathan J. Cherrington, Hozumi Motohashi, Yuji Tanaka and Lauren M. Aleksunes. Their work appears in journals such as Drug Metabolism and Disposition, Toxicology and Applied Pharmacology, Molecular and Cellular Biology, Toxicological Sciences and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.